All companies
Visit website
NIRA Skin
OperatingDermal Photonics Corp
Healthcare · Founded 2012
Dermatology at Home
Post-money valuation ⓘ
$16.0M
As of Apr 2020 · from Reg CF Offering (2020) · pre-money + amount raised, not a traded price
Total raised
$39,871
Across 1 round since 2020
Latest share price
$1.06
Reg CF Offering (2020) offering price
Financials
FY2017–FY2018 · from SEC filings · hover any figure for its source$25K
−$237K
2017
$2K
−$336K
2018
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2017
FY2018
Income statement
Revenue
$25,475
$2,388
Cost of goods sold
$2,233
$56,845
Gross margin
91%
-2280%
Net income
-$237,396
-$335,730
Taxes paid
$0
$0
Balance sheet
Cash
$13,963
$726,049
Accounts receivable
$0
$0
Total assets
$293,670
$1,171,976
Short-term debt
$119,627
$218,659
Long-term debt
$0
$500,000
Total liabilities
$119,627
$718,659
Other
Headcount
—
8
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$16.0M
post-money
Reg CF Offering (2020)
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $39.9K / $107KInvestors 0Post-money $16M
Reg CF annual-report compliance
Not obligated
never closed a Reg CF raise
0 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001797421Share price $1.06
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.